Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Sanofi Expects Dengue Vaccine Clinical Trial Results In September

Reuters: Sanofi faces make-or-break verdict on big dengue vaccine bet “Sanofi expects final clinical results for its vaccine against dengue by late September, the French drugmaker’s project leader has told Reuters, and has already gambled on starting production despite some disappointing early trials data. Sanofi has invested more than one…

Myanmar Remains Potential ‘Gateway’ for Spread Of Drug-Resistant Malaria, Experts Warn

IRIN: Curbing Myanmar’s spread of drug-resistant malaria “Efforts to halt the spread of drug-resistant malaria in Myanmar have delivered encouraging results through the private health sector, but health experts warn the [fight against the] disease cannot be won outside the public health system — and that the country is still…

Drugmaker GlaxoSmithKline To Invest $216M In Factories, R&D In Africa

Reuters: Drugmaker GSK to invest $200 million in African factories, R&D “Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent’s swelling urban middle classes…” (Hirschler, 3/31).

Global Action Plan For Newborns Announced At MNCH Partners’ Forum

World Health Organization: Landmark global action plan outlines strategy to prevent 2.9 million newborn deaths “…New financial, policy, and private sector commitments to save newborn lives from 40 partners [are] to be announced at 2014 Partners’ Forum. Investments in quality care at birth could save the lives of three million…

Global Development Lab Act Introduced In Senate

Center for Global Health Policy’s “Science Speaks”: USAID Global Development Lab bill introduced in Senate Rabita Aziz, policy research coordinator for the Center for Global Health Policy, discusses the USAID Global Development Lab bill that was introduced in the U.S. Senate in June and would authorize USAID “to expand public-private…

‘Urgent’ Global Action Needed To Tackle Antibiotic Resistance

Financial Times: Keep medicine out of the dark ages “David Cameron has added his voice to increasingly urgent warnings by the world’s public health leaders about the growth of antibiotic resistance. Besides talking about a return to ‘the dark ages of medicine’ if we lose our power to kill microbes,…

Drug Resistance Is Economic, National Security Issue, Reuters Reports

Reuters: How to fix a broken market in antibiotics “…Waking up to the threat [of antibiotic drug resistance], governments and health officials are getting serious about trying to neutralize it. It may seem like a question of science, microbes, and drugs — but in truth it is a global issue…

Public-Private Partnerships Can Further Global Health Efforts, Says Shah

GlobalPost: Public-private partnerships: A ‘win-win’ for global health? “When USAID Administrator Rajiv Shah announced more than $600 million in new partnerships with private organizations last month, including giant multinationals Coca-Cola and Johnson & Johnson, the news was heralded in Washington as another stride in the agency’s path to ending preventable…

Public-Private Partnership Brings Drugs, Essential Medical Supplies To Remote Areas

Huffington Post: Going the Extra Mile for Health Wendy Taylor, director of the Center for Accelerating Innovation and Impact at USAID, and Michael Goltzman, vice president of international government relations & public affairs at the CocaCola Company “…Five years ago, the Global Fund to Fight AIDS, Tuberculosis and Malaria turned…

Blog Post Discusses Private Financing In Uganda’s Health Sector

USAID’s “Impact”: Can Private Financing Answer Uganda’s Health Care Woes? Daryl Martyris, a health development officer in USAID Uganda’s Office of Health, HIV/AIDS and Education, discusses private financing for health in Uganda (7/8).